Janine Poss

Showing 1-3 of 3 articles

Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial

Saad M, Fuernau G, Desch S, Eitel I, de Waha S, Poss J, Ouarrak T, Schneider S, Zeymer U, Thiele H

June 14, 2018 | 10.4244/EIJ-D-17-00451

Coronary interventions

ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis

Orban M, Limbourg T, Neumann F, Ferenc M, Olbrich H-G, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Poss J, Schneider S, Schuler G, Werdan K, Zeymer U, Thiele H, Hausleiter J

December 9, 2016 | 10.4244/EIJY15M12_04

Shock management in acute myocardial infarction

Poss J, Desch S, Thiele H

August 19, 2014 | 10.4244/EIJV10STA12

1

Latest news

STATE OF THE ART

Transcatheter treatment for tricuspid valve disease

This State-of-the-Art - by F. Praz et al - reviews the available transcatheter therapies, main criteria for patient and device selection, remaining uncertainties, and future directions

November 19, 2021

PCR London Valves Edition: state of the art on transcatheter treatment for tricuspid valve disease, a mini focus on TR; coronary access after TAVI and more…

November 19, 2021

EuroIntervention is now on Instagram

November 29, 2021

Long-term impact of OCT-assessed suboptimal stent deployment

Francesco Prati et al.

November 25, 2021

Percutaneous tricuspid valve annuloplasty: additional data and remaining questions

Nicole Karam et al.

November 23, 2021

Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?

Josep Rodés-Cabau et al.

November 23, 2021

Guidelines, consensus & position papers

consult the most recent published guidelines, consensus and position papers

November 29, 2021

Valvular disease